Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Glendale, California 91206


Purpose:

This is a Phase 1 study in healthy subjects to evaluate the safety and tolerability of LY2886721 multiple doses, how the body handles the drug, and the drug's effect on the body.


Criteria:

Inclusion Criteria: - Healthy men and non-childbearing potential women - Body mass index between 18.0-32.0 kilograms per square meter (kg/m^2) - Are reliable and willing to make yourself available for the duration of the study and are willing to follow study procedures and research unit policies Exclusion Criteria: - Taking over-the-counter or prescription medication with the exception of vitamins or minerals - Smoke more than 10 cigarettes per day - Drink more than 5 cups of caffeine containing beverages (for example, coffee, tea) per day


NCT ID:

NCT01227252


Primary Contact:

Study Director
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company


Backup Contact:

N/A


Location Contact:

Glendale, California 91206
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 31, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.